GlucaGen is a Intramuscular; Intravenous; Subcutaneous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Glucagon Hydrochloride.
| Product ID | 0597-0053_0ff3a5b5-37eb-4bc4-a423-a218a0dbd8a2 |
| NDC | 0597-0053 |
| Product Type | Human Prescription Drug |
| Proprietary Name | GlucaGen |
| Generic Name | Glucagon Hydrochloride |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2005-06-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020918 |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | GLUCAGON HYDROCHLORIDE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2005-06-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020918 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-06-22 |
| Ingredient | Strength |
|---|---|
| GLUCAGON HYDROCHLORIDE | 1 mg/mL |
| SPL SET ID: | ff16e4b1-3668-4cb4-91a4-77ee509cd6f6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0053 | GlucaGen | glucagon hydrochloride |
| 0597-0260 | GlucaGen | glucagon hydrochloride |
| 0169-7065 | GlucaGen HypoKit | glucagon hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GLUCAGEN 77009824 3254580 Live/Registered |
Novo Nordisk A/S 2006-09-28 |
![]() GLUCAGEN 74145009 1841542 Dead/Cancelled |
NOVO NORDISK A/S 1991-03-06 |